NL7007379A - - Google Patents

Info

Publication number
NL7007379A
NL7007379A NL7007379A NL7007379A NL7007379A NL 7007379 A NL7007379 A NL 7007379A NL 7007379 A NL7007379 A NL 7007379A NL 7007379 A NL7007379 A NL 7007379A NL 7007379 A NL7007379 A NL 7007379A
Authority
NL
Netherlands
Application number
NL7007379A
Other versions
NL166462C (nl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7007379A publication Critical patent/NL7007379A/xx
Application granted granted Critical
Publication of NL166462C publication Critical patent/NL166462C/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
    • C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/24—Ethers with hydroxy compounds containing no oxirane rings with polyhydroxy compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NL7007379.A 1969-05-21 1970-05-21 Werkwijze voor het bereiden of vervaardigen van een preparaat tegen hartkwalen dat een 1-(4-alkoxyfenoxy)-2-hydroxy-3-alkylaminopropaanderi- vaat en/of een zuuradditiezout daarvan bevat, en werk- wijze voor het bereiden van de daarbij toegepaste 1-(4-alkoxyfenoxy)-2-hydroxy-3-alkylaminopropaanderi- vaten en de zuuradditiezouten daarvan. NL166462C (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE6907153A SE372762B (es) 1969-05-21 1969-05-21

Publications (2)

Publication Number Publication Date
NL7007379A true NL7007379A (es) 1970-11-24
NL166462C NL166462C (nl) 1981-08-17

Family

ID=20270562

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7007379.A NL166462C (nl) 1969-05-21 1970-05-21 Werkwijze voor het bereiden of vervaardigen van een preparaat tegen hartkwalen dat een 1-(4-alkoxyfenoxy)-2-hydroxy-3-alkylaminopropaanderi- vaat en/of een zuuradditiezout daarvan bevat, en werk- wijze voor het bereiden van de daarbij toegepaste 1-(4-alkoxyfenoxy)-2-hydroxy-3-alkylaminopropaanderi- vaten en de zuuradditiezouten daarvan.

Country Status (18)

Country Link
US (1) US3674840A (es)
JP (2) JPS5123488B1 (es)
AT (3) AT308723B (es)
BE (1) BE749244A (es)
CA (1) CA979460A (es)
CH (3) CH564512A5 (es)
CS (3) CS167284B2 (es)
DE (1) DE2020864C3 (es)
DK (1) DK136527B (es)
ES (3) ES379062A1 (es)
FI (1) FI55175C (es)
FR (1) FR2044806B1 (es)
GB (1) GB1298017A (es)
IE (1) IE34201B1 (es)
NL (1) NL166462C (es)
NO (1) NO129792B (es)
PL (3) PL72300B1 (es)
SE (1) SE372762B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE384853B (sv) * 1972-04-04 1976-05-24 Haessle Ab Forfarande for framstellning av nya aminer
GB1312555A (en) * 1971-02-09 1973-04-04 Ici Ltd Alkanolamine derivatives
GB1387630A (en) * 1971-05-07 1975-03-19 Ici Ltd Phenoxyalkanolamine derivatives
SE386892B (sv) * 1972-07-06 1976-08-23 Haessle Ab Forfarande for framstellning av oxaminoforeningar
CH585693A5 (es) * 1974-02-08 1977-03-15 Ciba Geigy Ag
FR2330383A1 (fr) * 1975-11-06 1977-06-03 Synthelabo Nouveaux ethers de phenols substitues, leurs sels, leur preparation et les medicaments qui les renferment
DE2645710C2 (de) * 1976-10-09 1985-06-27 Merck Patent Gmbh, 6100 Darmstadt Phenoxy-amino-propanole, Verfahren zu ihrer Herstellung und pharmazeutische Zubereitung
IT1147311B (it) * 1980-02-13 1986-11-19 Stabil Bioterapico Farmachim Eteri basici di 4-idrossi-benzofenoni con attivita' quali agenti betabloccanti e relativi procedimento di preparazione
ZW9881A1 (en) * 1980-06-02 1981-12-23 Hoffmann La Roche Substituted phenoxyaminopropanol derivatives
US4342783A (en) * 1980-06-30 1982-08-03 Synthelabo Anti-glaucoma agent
ATE19510T1 (de) * 1981-12-17 1986-05-15 Haessle Ab Para-substituierte 3-phenoxy-1carbonylaminoalkylaminopropan-2-ole mit blockierenden wirkungen bei betarezeptoren.
US4968829A (en) * 1984-07-18 1990-11-06 Sandoz Ltd. Novel substituted aromatic compounds
US4568354A (en) * 1985-06-03 1986-02-04 Texaco Inc. Conversion of hazy gasoline to clear stable gasoline
EP0252007A3 (en) * 1986-06-28 1989-07-05 Ciba-Geigy Ag 2-propanol derivatives as corrosion inhibitors
DE3773188D1 (de) * 1987-03-26 1991-10-24 Helopharm Petrik Co Kg Verfahren zur herstellung von 5-hydroxydiprafenon und seiner salze mit saeuren.
MX2010011101A (es) * 2008-04-11 2010-11-01 Nektar Therapeutics Conjugados de oligomero-propanamina sustituida con ariloxi.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL300886A (es) * 1962-11-23
US3275629A (en) * 1963-03-20 1966-09-27 Monsanto Co Substituted aryloxyalkylene amines
GB1095378A (es) * 1965-06-22
JPS5318117B2 (es) * 1972-07-31 1978-06-13

Also Published As

Publication number Publication date
JPS5123488B1 (es) 1976-07-17
ES379062A1 (es) 1973-02-01
IE34201B1 (en) 1975-03-05
CS167284B2 (es) 1976-04-29
DE2020864C3 (de) 1981-01-08
GB1298017A (en) 1972-11-29
CA979460A (en) 1975-12-09
IE34201L (en) 1970-11-21
BE749244A (fr) 1970-10-01
NL166462C (nl) 1981-08-17
FR2044806A1 (es) 1971-02-26
FI55175B (fi) 1979-02-28
ES407663A1 (es) 1975-10-16
PL97061B1 (pl) 1978-02-28
DE2020864A1 (de) 1970-11-26
PL94849B1 (pl) 1977-08-31
PL72300B1 (es) 1974-06-29
JPS5247447B1 (es) 1977-12-02
FR2044806B1 (es) 1974-08-30
DK136527C (es) 1978-05-01
AT310145B (de) 1973-09-25
CS167282B2 (es) 1976-04-29
FI55175C (fi) 1979-06-11
US3674840A (en) 1972-07-04
DE2020864B2 (de) 1980-05-08
CH562776A5 (es) 1975-06-13
NO129792B (es) 1974-05-27
CS167283B2 (es) 1976-04-29
CH564514A5 (es) 1975-07-31
CH564512A5 (es) 1975-07-31
SE372762B (es) 1975-01-13
ES407664A1 (es) 1975-10-16
AT307384B (de) 1973-05-25
AT308723B (de) 1973-07-25
DK136527B (da) 1977-10-24

Similar Documents

Publication Publication Date Title
FR2044806B1 (es)
AU465413B2 (es)
AU5712069A (es)
AU470301B1 (es)
AU427401B2 (es)
AU470661B1 (es)
AU428129B2 (es)
AU5079269A (es)
AU4540468A (es)
CS148794B1 (es)
AU4923469A (es)
AU4949169A (es)
AU5077469A (es)
CH1429470D (es)
CH545824A (es)
BE760291A (es)
AU5006968A (es)
AU4953367A (es)
CH1203170A4 (es)
BE745440A (es)
BE730965A (es)
CH132669A4 (es)
AU4815038A (es)
BE743029A (es)
AU481328A (es)

Legal Events

Date Code Title Description
V1 Lapsed because of non-payment of the annual fee